Michael Weinreich

Michael Weinreich has a diverse work experience in the medical and pharmaceutical field. Michael is currently the VP & Head of Immunology & Inflammation Clinical Development at Apollo Therapeutics since February 2023. Prior to that, they worked as a Senior Medical Director at Revolo Biotherapeutics from July 2021 to February 2023. Before that, they held roles at AbbVie, starting as an Associate Medical Director in January 2018 and later becoming an Associate Medical Director Physician Development Program from November 2019 to July 2021. Michael also served as a Clinical Fellow in Allergy and Immunology at NIH Clinical Center from July 2015 to January 2018. Their earlier experience includes working as a Resident Physician at University of Maryland Medical Center from 2013 to 2015 and at University of Minnesota from 2012 to 2013.

Michael Weinreich attended Evergreen High School, but there is no information available about their degree or field of study during that time. Michael then went on to pursue an MD/PhD in Immunology at the University of Minnesota from 2004 to 2012. There is no information provided about any other educational experiences.